JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Pharma has scheduled a conference call for investors and analysts on Thursday, July 31, 2025 at 3:30 PM IST to discuss its financial results and business developments for Q1 FY26 (quarter ended June 30, 2025). The company's Q1 financial results will be announced the day before, on July 30, 2025. Senior management, including CFO Narayan Saraf and Executive Vice President Jason D'Souza, will be present to address participants. The call will run from 3:30 to 4:30 PM IST, with dial-in access available for participants in India, Hong Kong, Singapore, the UK, and the USA, as well as pre-registration through the company's website.
This is a routine pre-earnings call notice and is generally neutral for the stock. However, the actual Q1 results due on July 30, 2025 and management commentary on the call could trigger volatility, so investors should watch for the earnings announcement closely.